← Overview

Strategic Lens

Pharma and health: Brazil and United States

First country

Second country

In 2025, Brazil sold USD 241 million of pharmaceutical products to United States and bought USD 3.34 billion from it.

Benefits

  • BothTwo-way trade in pharmaceutical products grew 112 percent, from USD 1.69 billion in 2019 to USD 3.59 billion in 2025.

Constraints

  • BothFlows are one-sided: in 2025, United States sold USD 3.34 billion of pharmaceutical products, against USD 241 million the other way.

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Last updated on 26 September 2026

The numbers

Brazil's exports to United States: pharmaceutical products

USD million · 2019 to 2025, calendar years, as reported by Brazil

2019: 197.3Low 169.5 / High 240.62025: 240.6

2019197.3
2020189.1
2021176.1
2022195.9
2023169.5
2024180.8
2025240.6

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

Brazil's imports from United States: pharmaceutical products

USD billion · 2019 to 2025, calendar years, as reported by Brazil

2019: 1.49Low 1.38 / High 3.342025: 3.34

20191.49
20201.38
20213.31
20221.68
20231.85
20242.38
20253.34

Sources: UN Comtrade (public preview API), annual goods trade, HS classification (retrieved 26 September 2026)

Data retrieved 26 September 2026

← Brazil and United States